HETEROARYL UREA NEUROPEPTIDE Y Y5 RECEPTOR ANTAGONISTS
申请人:Schering Corporation
公开号:EP1343503B1
公开(公告)日:2008-11-12
US7309704B2
申请人:——
公开号:US7309704B2
公开(公告)日:2007-12-18
[EN] BIOLOGICALLY ACTIVE AMIDES<br/>[FR] AMIDES BIOLOGIQUEMENT ACTIFS
申请人:LUNDBECK & CO AS H
公开号:WO2010053861A2
公开(公告)日:2010-05-14
The present invention is directed to biologically active amides which are ligands at the NPY Y5 receptor. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from certain disorders which comprises administering to the subject an amount of a compound of the subject invention. Furthermore, this invention also provides uses of a compound of the invention for the manufacture of a medicament for treating a subject suffering from certain disorders.
BIOLOGICALLY ACTIVE AMIDES
申请人:Peterson John Matthew
公开号:US20110230497A1
公开(公告)日:2011-09-22
The present invention is directed to biologically active amides which are ligands at the NPY Y5 receptor. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from certain disorders which comprises administering to the subject an amount of a compound of the subject invention. Furthermore, this invention also provides uses of a compound of the invention for the manufacture of a medicament for treating a subject suffering from certain disorders.